Rohispas D
Rohispas D Products are primarily used for
Abdominal pain
About Rohispas D Products
Rohispas D Products side effects
Common
Side Effects of Rohispas D are Nausea, Vomiting, Diarrhea, Dryness in mouth, Heartburn, Vertigo, Insomnia (difficulty in sleeping), Hypotension (low blood pressure), Fast heart rate, Sweating, Constipation, Increased liver enzymes, Increased white blood cell count (eosinophils), Decreased white blood cell count (lymphocytes), Low blood platelets, Purpura, Agranulocytosis (deficiency of granulocytes in the blood), Breathlessness, Ringing in ear, Abdominal pain, Flatulence, Indigestion, Stomach inflammation, Confusion, Depression.
How Rohispas D Products work
Drotaverine + Mefenamic Acid is a combination of two medicines: Drotaverine + Mefenamic Acid1 and Drotaverine + Mefenamic Acid2, which relieves abdominal pain and cramps. Drotaverine + Mefenamic Acid1 is an anti-spasmodic medicine which relieves contractions (spasms) associated with smooth muscles in the abdomen. Drotaverine + Mefenamic Acid2 is a non-steroidal anti-inflammatory drug (NSAID). It works by blocking the release of certain chemical messengers that cause abdominal pain and inflammation (swelling).
Patient Concerns about Rohispas D Products
Frequently asked questions about Rohispas D Products
Frequently asked questions about Rohispas D Products
Q. What is Rohispas D 80mg/250mg Tablet?
Rohispas D 80mg/250mg Tablet is a combination of two medicines: Drotaverine and Mefenamic acid. This medication helps to relieve abdominal pain. Drotaverine relieves muscle spasms associated with smooth muscles in the abdomen. Mefenamic Acid works by blocking the release of certain chemical messengers that cause pain and inflammation (swelling).
Q. Is it safe to use Rohispas D 80mg/250mg Tablet?
Yes, Rohispas D 80mg/250mg Tablet is safe for most of the patients with abdominal pain. However, in some patients it may cause common side effects like nausea, vomiting, heartburn, diarrhoea, loss of appetite, dryness in the mouth, weakness, sleepiness and other uncommon or rare side effects. If you experience any persistent problem while taking this medication, inform your doctor as soon as possible.
Q. Can I stop taking Rohispas D 80mg/250mg Tablet when my pain is relieved?
Rohispas D 80mg/250mg Tablet is usually used for short term and can be discontinued when your pain is relieved. However, Rohispas D 80mg/250mg Tablet should be continued if your physician has advised you to do so.
Q. Can the use of Rohispas D 80mg/250mg Tablet cause nausea and vomiting?
Yes, the use of Rohispas D 80mg/250mg Tablet can cause nausea and vomiting. Taking it with milk, food or with antacids can prevent nausea. In case of vomiting, drink plenty of water or other fluids by taking small and frequent sips. Also, avoid taking fatty or fried foods along with the medicine. Talk to your doctor if you have vomiting persists and you notice any signs of dehydration like less urination with dark coloured and strong-smelling urine. Do not take any other medicine without consulting your doctor.
Q. Can the use of Rohispas D 80mg/250mg Tablet cause dry mouth?
Yes, the use of Rohispas D 80mg/250mg Tablet can cause dry mouth. If you experience dry mouth, drink plenty of water. Take regular sips during the day and keep some water by your bed at night. You may use lip balm if your lips are also dry. Avoid spicy, salty and acidic foods (like lemons).
Q. Can I take a higher than the recommended dose of this medicine?
No, do not take a higher than the recommended dose of Rohispas D 80mg/250mg Tablet as it can increase the risks of side effects. If you are experiencing increased severity of pain or the pain is not relieved by the recommended doses, please consult your doctor for re-evaluation.
Q. What are the recommended storage conditions for Rohispas D 80mg/250mg Tablet?
Keep this medicine in the container or the pack it came in, tightly closed. Store it according to the instructions mentioned on the pack or label. Dispose of the unused medicine. Make sure it is not consumed by pets, children and other people.